Look Under The Hood: IHF Has 13% Upside

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares U.S. Healthcare Providers ETF ( IHF), we found that the implied analyst target price for the ETF based upon its underlying holdings is $139.31 per unit.

START SLIDESHOW:
10 ETFs With Most Upside To Analyst Targets »

With IHF trading at a recent price near $123.50 per unit, that means that analysts see 12.80% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of IHF's underlying holdings with notable upside to their analyst target prices are Centene Corp ( CNC), Healthways Inc ( HWAY), and Ensign Group Inc ( ENSG). Although CNC has traded at a recent price of $55.61/share, the average analyst target is 47.82% higher at $82.20/share. Similarly, HWAY has 16.20% upside from the recent share price of $23.05 if the average analyst target price of $26.79/share is reached, and analysts on average are expecting ENSG to reach a target price of $24.20/share, which is 13.56% above the recent price of $21.31. Below is a twelve month price history chart comparing the stock performance of CNC, HWAY, and ENSG:

CNC, HWAY, and ENSG Relative Performance Chart

Below is a summary table of the current analyst target prices discussed above:

Name Symbol Recent Price Avg. Analyst 12-Mo. Target % Upside to Target
iShares U.S. Healthcare Providers ETF IHF $123.50 $139.31 12.80%
Centene Corp CNC $55.61 $82.20 47.82%
Healthways Inc HWAY $23.05 $26.79 16.20%
Ensign Group Inc ENSG $21.31 $24.20 13.56%

Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.

If you liked this article you might like

Battered Pharma Stocks Bounce Back, Could Boost Retirement Portfolios

Biotech Leads the Way in Health Care Stocks to Boost 401(k) Returns

12 Best Biotech and Health Care ETFs to Add to Your Portfolio

Notable ETF Outflow Detected - IHF, ANTM, AET, CI

Health Care Select Is Among This Year’s Hottest Health Care ETFs